ObvioHealth Is Building A New Digital Ecosystem To 'Revolutionize' Trials
Executive Summary
Using artificial intelligence and strict data collection protocol, ObvioHealth hopes to digitize clinical trials with the assistance of medical devices and consumer technology.
You may also be interested in...
RedHill Could Soon Seek EUA For COVID-19 Therapy
The Israel-based, NASDAQ-listed biotech tells Scrip that if the oral SK2 selective inhibitor succeeds in a Phase II/III study, it would be "very comfortable" taking opaganib all the way to market on its own.
New Training Methods Could Reduce Bias In Artificial Intelligence
A “federated” training method could be used to reduce bias in AI, according to one expert on patient safety.
Exec Chat: Cumulus Neuroscience Help Trials Collect Previously Underutilized, Vital Data
Cumulus Neuroscience, previously known as BrainWaveBank, announced a £6m financing round to help develop its unique neurological data collection system.